Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC. This evidence concerns the gene MYL1 and head and neck squamous cell carcinoma.